Arcus与Gilead宣布TIGIT药物在上消化道癌症三期试验中未达预期

FierceBiotechChutes & Ladders—Helus shuffles out CEO after two months, adds experience to science board

FierceBiotechAfter Lilly’s $7B Kelonia deal, are there any in vivo CAR-T biotechs left to buy?

BioWorldSichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

BioWorldShanghai Meiyue Biotech Development presents new molecular glue degraders

BioWorldJiangsu Carephar Pharmaceutical describes new AT2 receptor agonists

BioWorldPharma industry faces long haul to get return on investment from AI

FierceBiotechAvalyn拟募资1.82亿美元上市，资助改良型呼吸药物三期试验

Thermo FisherThermo Fisher Scientific Q1 Earnings Call Highlights - Yahoo Finance

AgilentDoes Agilent (A) Settling Axion Dispute Clarify Its Push Into Cloud Lab Data Recurring Revenues? - simplywall.st

10x Genomics BlogWhy 10x Genomics (TXG) Shares Are Trading Lower Today - Yahoo Finance

10x Genomics BlogLiquidCell Dx 任命前 Foundation Medicine、10x Genomics 和 IDT 高管 Mirna Jarosz 为首席执行官；任命前 Foundation Medicine 首席医疗官 Vincent A. Miller 博士为高级战略顾问 - BioSpace

Thermo FisherThermo Fisher Scientific: Why A Slow Q1 Does Not Reflect The Growth Opportunities - Seeking Alpha